HEADER STRUCTURAL PROTEIN 31-MAR-06 2DJ4 TITLE SOLUTION STRUCTURE OF THE 13TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FILAMIN DOMAIN; COMPND 5 SYNONYM: FLN-B, BETA-FILAMIN, ACTIN-BINDING-LIKE PROTEIN, THYROID COMPND 6 AUTOANTIGEN, TRUNCATED ACTIN-BINDING PROTEIN, TRUNCATED ABP, ABP-280 COMPND 7 HOMOLOG, ABP-278, FILAMIN 3, FILAMIN HOMOLOG 1, FH1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLNB; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: P060123-13; SOURCE 9 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, IMMUNOGLOBULIN-LIKE FOLD, FILAMIN DOMAIN, NPPSFA, KEYWDS 2 NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, KEYWDS 3 STRUCTURAL GENOMICS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2DJ4 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DJ4 1 VERSN REVDAT 1 01-OCT-06 2DJ4 0 JRNL AUTH T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE 13TH FILAMIN DOMAIN FROM HUMAN JRNL TITL 2 FILAMIN-B JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN 1.3, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (TOPSPIN), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DJ4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000025473. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.16MM FILAMIN DOMAIN U-15N,13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20060324, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9742, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 75 97.12 -69.73 REMARK 500 1 PRO A 80 88.07 -69.78 REMARK 500 1 GLU A 91 109.50 -54.54 REMARK 500 1 ILE A 92 152.95 -47.52 REMARK 500 1 PRO A 93 3.93 -69.74 REMARK 500 1 PRO A 96 -179.97 -69.70 REMARK 500 1 THR A 104 -34.51 -34.70 REMARK 500 2 SER A 3 42.26 36.77 REMARK 500 2 PRO A 75 90.45 -69.74 REMARK 500 2 PRO A 80 86.59 -69.83 REMARK 500 2 ILE A 92 153.20 -49.24 REMARK 500 2 PRO A 93 4.41 -69.65 REMARK 500 2 THR A 104 -30.42 -36.34 REMARK 500 2 ALA A 107 78.73 -111.66 REMARK 500 3 SER A 6 90.54 -69.48 REMARK 500 3 PRO A 75 91.90 -69.73 REMARK 500 3 PRO A 80 90.85 -69.72 REMARK 500 3 PRO A 93 4.29 -69.76 REMARK 500 3 PRO A 96 -179.41 -69.69 REMARK 500 3 THR A 104 -36.21 -33.97 REMARK 500 4 PRO A 75 98.12 -69.77 REMARK 500 4 PRO A 80 92.76 -69.78 REMARK 500 4 ASP A 89 31.74 74.22 REMARK 500 4 PRO A 93 4.47 -69.80 REMARK 500 4 THR A 104 -31.75 -35.21 REMARK 500 5 PRO A 11 1.49 -69.76 REMARK 500 5 PRO A 75 92.92 -69.76 REMARK 500 5 PRO A 80 89.13 -69.76 REMARK 500 5 TYR A 87 110.54 -160.44 REMARK 500 5 GLU A 91 108.38 -54.39 REMARK 500 5 ILE A 92 153.02 -46.90 REMARK 500 5 PRO A 93 4.68 -69.74 REMARK 500 5 PRO A 96 -178.53 -69.72 REMARK 500 5 THR A 104 -35.32 -34.83 REMARK 500 6 PRO A 75 95.04 -69.80 REMARK 500 6 PRO A 80 89.15 -69.76 REMARK 500 6 PRO A 93 4.74 -69.74 REMARK 500 6 PRO A 96 -179.92 -69.69 REMARK 500 6 THR A 104 -32.19 -34.83 REMARK 500 6 TYR A 105 38.71 -90.05 REMARK 500 6 ALA A 107 78.53 -108.41 REMARK 500 7 PRO A 11 0.78 -69.74 REMARK 500 7 PRO A 80 93.93 -69.78 REMARK 500 7 ASP A 89 31.40 73.47 REMARK 500 7 GLU A 91 107.90 -53.36 REMARK 500 7 ILE A 92 153.00 -45.93 REMARK 500 7 PRO A 93 4.31 -69.75 REMARK 500 7 THR A 104 -32.15 -35.58 REMARK 500 7 ALA A 107 43.45 -79.87 REMARK 500 8 PRO A 75 91.39 -69.73 REMARK 500 REMARK 500 THIS ENTRY HAS 134 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK003002600.6 RELATED DB: TARGETDB DBREF 2DJ4 A 8 108 UNP O75369 FLNB_HUMAN 1418 1518 SEQADV 2DJ4 GLY A 1 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 SER A 2 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 SER A 3 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 GLY A 4 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 SER A 5 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 SER A 6 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 GLY A 7 UNP O75369 CLONING ARTIFACT SEQADV 2DJ4 VAL A 61 UNP O75369 MET 1471 SEE REMARK 999 SEQRES 1 A 108 GLY SER SER GLY SER SER GLY VAL VAL ASP PRO SER LYS SEQRES 2 A 108 VAL LYS ILE ALA GLY PRO GLY LEU GLY SER GLY VAL ARG SEQRES 3 A 108 ALA ARG VAL LEU GLN SER PHE THR VAL ASP SER SER LYS SEQRES 4 A 108 ALA GLY LEU ALA PRO LEU GLU VAL ARG VAL LEU GLY PRO SEQRES 5 A 108 ARG GLY LEU VAL GLU PRO VAL ASN VAL VAL ASP ASN GLY SEQRES 6 A 108 ASP GLY THR HIS THR VAL THR TYR THR PRO SER GLN GLU SEQRES 7 A 108 GLY PRO TYR MET VAL SER VAL LYS TYR ALA ASP GLU GLU SEQRES 8 A 108 ILE PRO ARG SER PRO PHE LYS VAL LYS VAL LEU PRO THR SEQRES 9 A 108 TYR ASP ALA SER SHEET 1 A 4 LYS A 15 ALA A 17 0 SHEET 2 A 4 GLN A 31 ASP A 36 -1 O ASP A 36 N LYS A 15 SHEET 3 A 4 THR A 68 TYR A 73 -1 O TYR A 73 N GLN A 31 SHEET 4 A 4 VAL A 62 ASP A 63 -1 N VAL A 62 O THR A 70 SHEET 1 B 4 VAL A 56 GLU A 57 0 SHEET 2 B 4 LEU A 45 LEU A 50 -1 N VAL A 49 O GLU A 57 SHEET 3 B 4 GLY A 79 TYR A 87 -1 O MET A 82 N LEU A 50 SHEET 4 B 4 PHE A 97 VAL A 101 -1 O VAL A 101 N GLY A 79 CISPEP 1 SER A 95 PRO A 96 1 -0.10 CISPEP 2 SER A 95 PRO A 96 2 -0.01 CISPEP 3 SER A 95 PRO A 96 3 -0.13 CISPEP 4 SER A 95 PRO A 96 4 0.08 CISPEP 5 SER A 95 PRO A 96 5 -0.08 CISPEP 6 SER A 95 PRO A 96 6 -0.11 CISPEP 7 SER A 95 PRO A 96 7 -0.12 CISPEP 8 SER A 95 PRO A 96 8 0.02 CISPEP 9 SER A 95 PRO A 96 9 -0.05 CISPEP 10 SER A 95 PRO A 96 10 -0.02 CISPEP 11 SER A 95 PRO A 96 11 -0.03 CISPEP 12 SER A 95 PRO A 96 12 -0.05 CISPEP 13 SER A 95 PRO A 96 13 0.11 CISPEP 14 SER A 95 PRO A 96 14 -0.05 CISPEP 15 SER A 95 PRO A 96 15 0.02 CISPEP 16 SER A 95 PRO A 96 16 0.02 CISPEP 17 SER A 95 PRO A 96 17 -0.02 CISPEP 18 SER A 95 PRO A 96 18 -0.05 CISPEP 19 SER A 95 PRO A 96 19 0.09 CISPEP 20 SER A 95 PRO A 96 20 0.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1